---
figid: PMC11034608__NRR-19-2299-g008
pmcid: PMC11034608
image_filename: NRR-19-2299-g008.jpg
figure_link: /pmc/articles/PMC11034608/figure/F7/
number: Figure 7
figure_title: ''
caption: 'A schematic model for the mechanism of p38 MAPK inhibitor SB202190 in alleviating
  ferroptosis in the glutamate-induced retinal excitotoxic glaucoma model.The p38
  MAPK inhibitor sB202190 inhibits ferroptosis in the glutamatergic excitotoxicity
  glaucoma model by upregulation of ferritin light chain (FTL), downregulation of
  SAT1 and regulation of the SLC7A11/GSH/GPx4 signaling pathway. GPx4: Glutathione
  peroxidase 4; GSH: glutathione; GSSG: glutathione disulfide; MAPK: mitogen-activated
  protein kinase; ROS: reactive oxygen species.'
article_title: p38 MAPK inhibitor SB202190 suppresses ferroptosis in the glutamate-induced
  retinal excitotoxicity glaucoma model.
citation: Lemeng Feng, et al. Neural Regen Res. 2024 Oct;19(10):2299-2309.
year: '2024'

doi: 10.4103/1673-5374.391193
journal_title: Neural Regeneration Research
journal_nlm_ta: Neural Regen Res
publisher_name: Wolters Kluwer - Medknow

keywords:
- ferroptosis
- glaucoma
- glutamate excitotoxicity
- p38 MAPK
- retinal ganglion cell
- SB202190

---
